Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q2 2016 call → NOWe need to determine if management describes an identifiable offering/initiative that is still small relative to total business, with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more resources behind it. Scan transcript. Management talks about DatAlert, ransomware, insider threat, etc. They mention strong momentum, but do they say that a specific offering's uptake is exceeding their preparation? They mention "we see strong momentum" and "third quarter in a row of going both license and total revenues with 30% or more" but that's overall business. They mention "Our [SIEM] solution increased globally" but not specific to a small offering. They talk about "DatAlert" as a product, but they don't say that customer response is running ahead of what they prepared for. They say "Ransomware continues to be strong driver for our business not just because DatAlert detects it" but that's about overall business. They mention "we conducted 23 worldwide Varonis Connect events and attendance nearly doubled" - that's marketing events, not a specific offering. They mention "Our insider threat complaints generate awareness in web traffic and our trial and demo requests nearly doubled" - that's interest, not actual uptake. They don't describe a specific offering that is small and outrunning preparation. They talk about overall growth. They also mention "we are focused on adding people to deliver innovation and expanding self-capacity" but that's general. No specific offering with both conditions. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).